Published in Histopathology on May 01, 1996
Liver cell adenoma and liver cell adenomatosis. HPB (Oxford) (2005) 1.56
Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford) (2010) 1.51
Immunohistochemical features of the gastrointestinal tract tumors. J Gastrointest Oncol (2012) 1.06
Liver cell adenoma with malignant transformation: a case report. World J Gastroenterol (2003) 0.97
Liver cell adenoma: a case report with clonal analysis and literature review. World J Gastroenterol (2006) 0.81
Hepatocellular adenoma: An update. World J Hepatol (2015) 0.78
[Hepatocellular adenoma. Malignancy potential and differentiation from hepatocellular carcinoma]. Pathologe (2006) 0.77
QBend 10 (CD34) in the diagnosis of hepatocellular carcinoma. Histopathology (1996) 0.75
Retracted Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet (1998) 36.93
Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology (1994) 7.89
The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med (1973) 6.65
A classification of chronic hepatitis. Lancet (1968) 6.07
Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet (1989) 5.70
Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut (1980) 4.09
Hepatocytes from non-hepatic adult stem cells. Nature (2000) 3.27
A controlled trial of D-penicillamine therapy in primary biliary cirrhosis. Lancet (1977) 2.90
Granulomatous vasculitis in Crohn's disease. Gastroenterology (1991) 2.72
Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol (1984) 2.63
Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. Lancet (1970) 2.60
Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol (1999) 2.53
Partial nodular transformation of the liver with portal hypertension. Am J Med (1966) 2.45
PGP 9.5--a new marker for vertebrate neurons and neuroendocrine cells. Brain Res (1983) 2.41
Impaired delayed hypersensitivity in primary biliary cirrhosis. Lancet (1969) 2.19
The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol (1978) 2.13
Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. Liver (1999) 2.01
Hereditary spherocytosis with secondary haemochromatosis. Lancet (1968) 2.00
PGP 9.5, a new marker for human neuroendocrine tumours. Histopathology (1985) 1.97
An appraisal of the histopathological assessment of liver fibrosis. Gut (2006) 1.87
Proposal for standardized criteria for the diagnosis of benign, borderline, and malignant hepatocellular lesions arising in chronic advanced liver disease. Am J Surg Pathol (1993) 1.84
Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J Infect Dis (1999) 1.84
Hepatitis C virus transmitted by human bite. Lancet (1990) 1.77
Evidence of persistent measles virus infection in Crohn's disease. J Med Virol (1993) 1.76
QBEnd/10: a new immunostain for the routine diagnosis of Kaposi's sarcoma. J Pathol (1990) 1.76
8-Hydroxymanzamine A, a beta-carboline alkaloid from a sponge, Pachypellina sp. J Nat Prod (1994) 1.70
Primary sclerosing cholangitis, the biliary tree, and ulcerative colitis. Gut (1967) 1.67
The immunolocalization of protein gene product 9.5 using rabbit polyclonal and mouse monoclonal antibodies. Br J Exp Pathol (1988) 1.67
Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease. Gut (1988) 1.67
Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrates in patients with congenital coagulation disorders. Gut (1981) 1.67
Presentation and course of asymptomatic primary biliary cirrhosis. Gastroenterology (1977) 1.65
Liver damage due to methotrexate in patients with psoriasis. Br Med J (1971) 1.62
Thapsigargin, a histamine secretagogue, is a non-12-O-tetradecanoylphorbol-13-acetate (TPA) type tumor promoter in two-stage mouse skin carcinogenesis. J Cancer Res Clin Oncol (1986) 1.61
Transjugular liver biopsy: how good is it for accurate histological interpretation? Gut (2006) 1.61
Natural history of hepatitis-associated antigen-positive chronic liver disease. Lancet (1972) 1.59
Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies. Br J Dermatol (2014) 1.57
Arsenic and noncirrhotic portal hypertension. Gastroenterology (1974) 1.57
Palytoxin: a new marine toxin from a coelenterate. Science (1971) 1.56
Hepatobiliary fibropolycystic diseases. A clinical and histological review of 51 patients. J Hepatol (1986) 1.55
Liver biopsy in the diagnosis of cirrhosis. Gut (1970) 1.53
Percutaneous liver biopsy in patients with large bile duct obstruction. Gastroenterology (1975) 1.53
Angiosarcoma of the liver: annual occurrence and aetiology in Great Britain. Br J Ind Med (1980) 1.52
Is mitochondrial antibody diagnostic of primary biliary cirrhosis? Gut (1981) 1.50
Studies in alcoholic liver disease in Britain. I. Clinical and pathological patterns related to natural history. Gut (1974) 1.50
The pathology of diabetic hepatitis. J Pathol (1988) 1.48
Small hepatocellular carcinomas in cirrhotic explant livers: identification by macroscopic examination and lipiodol localization. Hepatology (1997) 1.48
Hepatic reactions associated with ketoconazole in the United Kingdom. Br Med J (Clin Res Ed) (1987) 1.47
D-penicillamine treatment improves survival in primary biliary cirrhosis. Lancet (1981) 1.45
Immunoglobulin-containing cells in the liver. Clin Exp Immunol (1969) 1.44
Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology (2000) 1.44
Genomic heterogeneity in synchronous hepatocellular carcinomas. Gut (1999) 1.44
Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J Viral Hepat (2000) 1.43
Hepatobiliary changes in erythropoietic protoporphyria. Arch Pathol (1965) 1.43
Histological demonstration of copper and copper-associated protein in chronic liver diseases. J Clin Pathol (1978) 1.42
Orcein staining of hepatitis B antigen in paraffin sections of liver biopsies. J Clin Pathol (1975) 1.41
Review article: the pharmacological implications of leucocyte-endothelial cell interactions in Crohn's disease. Aliment Pharmacol Ther (1991) 1.40
Vascular invasion and herniation by hepatocellular carcinoma in cirrhosis: A wolf in sheep's clothing? Arch Pathol Lab Med (2005) 1.39
The morphology of cirrhosis: definition, nomenclature, and classification. Bull World Health Organ (1977) 1.37
Idiopathic acute fatty liver of pregnancy in 12 patients. Q J Med (1982) 1.36
Prognosis of chronic persistent hepatitis. Lancet (1970) 1.35
Ciguatoxin: isolation and chemical nature. Science (1967) 1.35
Presymptomatic Wilson's disease. Lancet (1967) 1.33
Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol (2007) 1.33
Immunological and histological studies in primary biliary cirrhosis. J Clin Pathol (1970) 1.29
Incidence and survival for cancer in children and young adults in the North of England, 1968-1995: a report from the Northern Region Young Persons' Malignant Disease Registry. Br J Cancer (2000) 1.29
Neurone specific enolase: an aid to the diagnosis of melanoma and neuroblastoma. Histopathology (1982) 1.27
Angiosarcoma of the liver in Great Britain, 1963-73. Br Med J (1977) 1.26
Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection. J Viral Hepat (2002) 1.22
Methotrexate hepatotoxicity in psoriasis--comparison of different dose regimens. Br Med J (1972) 1.19
Jaundice due to oxyphenisatin. Lancet (1971) 1.19
Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut (1994) 1.18
The value of rectal biopsy in distinguishing self-limited colitis from early inflammatory bowel disease. Q J Med (1987) 1.18
Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine. J Clin Pathol (1987) 1.17
Early mucosal changes in Crohn's disease. Gut (1993) 1.16
Fibrolamellar hepatocellular carcinoma: prolonged survival with multimodality therapy. Eur J Surg Oncol (2009) 1.12
New triterpenoid sulfates from the red alga Tricleocarpa fragilis. J Nat Prod (2000) 1.11
Persistent measles virus infection of the intestine: confirmation by immunogold electron microscopy. Gut (1995) 1.10
Hepatocellular ballooning after liver transplantation: a light and electronmicroscopic study with clinicopathological correlation. Histopathology (1991) 1.10
New lipopeptides from the Caribbean cyanobacterium Lyngbya majuscula. J Nat Prod (2001) 1.09
A new depsipeptide from the sacoglossan mollusk Elysia ornata and the green alga Bryopsis species. J Nat Prod (2000) 1.09
Epidermal growth factor receptor expression and activation in neuroendocrine tumours. J Neuroendocrinol (2006) 1.09
Chronic hepatitis: a problem for the pathologist. Histopathology (1977) 1.07
Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation. Aliment Pharmacol Ther (1994) 1.07
Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection. J Viral Hepat (2007) 1.07
Neuroblastoma: changing incidence and survival in young people aged 0-24 years. A report from the North of England Young Persons' Malignant Disease Registry. Med Pediatr Oncol (2001) 1.06
Hepatitis B virus carriers without precore mutations in hepatitis B e antigen-negative stage show more severe liver damage. Hepatology (1996) 1.05
Rifampicin hepatitis. A clinical and histological study. Lancet (1974) 1.05
Asymptomatic primary biliary cirrhosis. Gut (1973) 1.05
Prognostic significance of intratumoural microvessel density (IMD) in resected pancreatic and ampullary cancers to standard histopathological variables and survival. Eur J Surg Oncol (2002) 1.05
Crohn's disease: pathogenesis and persistent measles virus infection. Gastroenterology (1995) 1.05
The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis. Hepatology (1986) 1.04
Immunohistochemical staining of granular cell tumour for neurone specific enolase: evidence in support of a neural origin. Diagn Histopathol (1983) 1.04
Expression of beta-2-microglobulin on hepatocytes after liver transplantation. Lancet (1985) 1.04
Variation in subcapsular liver structure and its significance in the interpretation of wedge biopsies. J Clin Pathol (1967) 1.04
Is copper hepatotoxic in primary biliary cirrhosis? J Clin Pathol (1981) 1.03